Panelists Steve Moore and Kevin Brady discussed U.S. economic data and the effects of President Donald Trump’s policies on the

Market Insights from Jim Cramer CNBC’s Jim Cramer analyzes the current market trends, focusing on potential bubbles in AI stocks.

Market Insights from Jim Cramer Jim Cramer of CNBC analyzed the current market trends, emphasizing concerns about a potential bubble

Consumer Sentiment Drops in September

Sentiment Index Declines Amid Economic Concerns The latest monthly survey reveals a drop in the sentiment index, reflecting growing concerns

US-Mexico Trade Changes Under Trump Trade between the US and Mexico has evolved significantly since President Trump’s inauguration, with tariffs

U.S. Markets Close Higher U.S. stock markets closed higher, buoyed by positive investor sentiment across all sectors. The S&P 500

Tame Inflation and Stronger Real Growth Indicate Positive Economic Trends Wharton professor Jeremy Siegel discussed the latest PCE report, noting

Market Insights Amid Third Quarter Conclusion Jeff Kilburg, CEO of KKM Financial, shared insights on ‘Power Lunch’ regarding equity performance

Federal Reserve Insights Bloomberg’s “Real Yield” features key insights from notable financial experts, including Wolfe Research Chief Economist Stephanie Roth

Trump Announces New Tariffs President Trump has announced new tariffs aimed at specific imports, sparking discussions about market implications. Analysts

Concerns About AI Investments Roger McNamee, co-founder of Elevation Partners, shared his apprehensions about the current AI investment landscape during

Trump Administration Implements New Tariffs President Trump announced new tariffs affecting a wide range of products, including furniture and pharmaceuticals.

Pharmaceutical Tariffs Discussion John Flavin, CEO of Portal Innovations, addressed the Trump administration’s proposed pharmaceutical tariffs during his appearance on

Market Outlook Amid Government Shutdown Dan Greenhaus, chief strategist at Solus Alternative Asset Management, shared insights on CNBC’s ‘Squawk on